205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
91.94%
Revenue growth above 1.5x LSCC's 10.39%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
122.82%
Gross profit growth above 1.5x LSCC's 10.87%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
188.14%
EBIT growth above 1.5x LSCC's 17.81%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
188.14%
Operating income growth above 1.5x LSCC's 17.81%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
560.71%
Net income growth above 1.5x LSCC's 13.27%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
589.13%
EPS growth above 1.5x LSCC's 330.77%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
589.13%
Diluted EPS growth above 1.5x LSCC's 330.77%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.32%
Share reduction more than 1.5x LSCC's 0.88%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
3.74%
Diluted share count expanding well above LSCC's 3.84%. Michael Burry would fear significant dilution to existing owners' stakes.
-0.32%
Dividend reduction while LSCC stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-54.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-88.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
43.31%
10Y revenue/share CAGR under 50% of LSCC's 518.59%. Michael Burry would suspect a lasting competitive disadvantage.
-15.35%
Negative 5Y CAGR while LSCC stands at 125.71%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.62%
Negative 3Y CAGR while LSCC stands at 49.30%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
2204.86%
Positive OCF/share growth while LSCC is negative. John Neff might see a comparative advantage in operational cash viability.
-32.61%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
39.09%
10Y net income/share CAGR of 39.09% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
104.35%
5Y net income/share CAGR at 50-75% of LSCC's 204.58%. Martin Whitman might see a shortfall in operational efficiency or brand power.
-7.92%
Negative 3Y CAGR while LSCC is 82.45%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
40.90%
Below 50% of LSCC's 251.75%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
63.10%
Below 50% of LSCC's 130.03%. Michael Burry suspects a serious short-term disadvantage in building book value.
101.36%
Dividend/share CAGR of 101.36% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-22.01%
Negative 5Y dividend/share CAGR while LSCC stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
80.04%
3Y dividend/share CAGR of 80.04% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.56%
Firm’s AR is declining while LSCC shows 13.10%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.69%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.04%
Negative asset growth while LSCC invests at 6.30%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.01%
50-75% of LSCC's 4.40%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
20.71%
R&D growth drastically higher vs. LSCC's 4.35%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
8.55%
SG&A growth well above LSCC's 5.88%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.